V025-3049 Screening compound: N-benzyl-4-({[4,5-dimethyl-6-(morpholin-4-yl)pyrimidin-2-yl]sulfanyl}methyl)-N-methylbenzamide

V025-3049 Screening compound: N-benzyl-4-({[4,5-dimethyl-6-(morpholin-4-yl)pyrimidin-2-yl]sulfanyl}methyl)-N-methylbenzamide
V025-3049 Screening compound: N-benzyl-4-({[4,5-dimethyl-6-(morpholin-4-yl)pyrimidin-2-yl]sulfanyl}methyl)-N-methylbenzamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V025-3049
N-benzyl-4-({[4,5-dimethyl-6-(morpholin-4-yl)pyrimidin-2-yl]sulfanyl}methyl)-N-methylbenzamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V025-3049

Molecular Formula

C26H30N4O2S (C26 H30 N4 O2 S)

Compound Name

N-benzyl-4-({[4,5-dimethyl-6-(morpholin-4-yl)pyrimidin-2-yl]sulfanyl}methyl)-N-methylbenzamide

IUPAC name

N-benzyl-4-({[45-dimethyl-6-(morpholin-4-yl)pyrimidin-2-yl]sulfanyl}methyl)-N-methylbenzamide

SMILES

Cc(c(C)n1)c(N2CCOCC2)nc1SCc(cc1)ccc1C(N(C)Cc1ccccc1)=O

InChI

InChI=1S/C26H30N4O2S/c1-19-20(2)27-26(28-24(19)30-13-15-32-16-14-30)33-18-22-9-11-23(12-10-22)25(31)29(3)17-21-7-5-4-6-8-21/h4-12H,13-18H2,1-3H3

InChI Key

VMHZINDLSSUQRP-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19835953

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

462.62

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

4.346

Distribution Coefficient, logD

4.345

Water Solubility, LogSw

-4.20

Polar Surface Area

45.281

Acid Dissociation Constant (pKa)

22.01

Base Dissociation Constant (pKb)

4.99

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

34.60

V025-3049 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

PI3K-Targeted Library (17255 compounds)

Akt-Targeted Library (14764 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
Targets:
  • Kinases
  • Kinases

References: we are preparing a list of scientific research reports with V025-3049 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V025-3049?
Check Price and Availability of V025-3049, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V025-3049 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V025-3049
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V025-3049
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V025-3049 available by request